Epitra 500 Tablet
Marketer
Linux Laboratories
Salt Composition
Levetiracetam (500mg)
Overview Epitra 500 Tablet
Epilepsy medication, Epitra 500mg tablets, controls seizures by regulating abnormal brain electrical activity. This anticonvulsant can be administered alone or in conjunction with other medications, offering ongoing seizure prevention with consistent usage. Take it with or without food, but maintain a regular daily schedule for optimal efficacy. Dosage is individualized based on patient response and condition, determined by your physician. Long-term therapy is typically recommended; discontinue only under your doctor's guidance, as abrupt cessation or missed doses may exacerbate seizures. Potential side effects, including drowsiness, headaches, irritability, altered behavior (including aggression), and reduced appetite, are most frequent initially, often subsiding with continued use. While most are minor, some could be severe. Rarely, suicidal ideation has been reported; report any significant mood changes to your doctor immediately. Prior to commencing treatment, disclose any pre-existing kidney issues, depression, suicidal tendencies, pregnancy, pregnancy plans, or breastfeeding to your physician. Regular blood tests to monitor kidney function may be recommended during treatment.
Uses of Epitra 500 Tablet
Managing Epileptic Seizures
Major Benefits of Epitra 500 Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Epitra 500 Tablet can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Epitra 500 Tablet:
- Sleepiness
- Dizziness
- Fatigue
- Headache
- Decreased appetite
- Behavioral changes
- Aggressive behavior
- Irritation
- Agitation
- Nasal congestion (stuffy nose)
- Infection
- Convulsion
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Nausea
- Tremors
- Vertigo
- Lethargy
How to use Epitra 500 Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Epitra 500 Tablets can be consumed with or without food; however, consistent timing is recommended.
How Epitra 500 Tablet works:
Epitra 500 Tablets contain an anticonvulsant drug. Its mechanism of action involves binding to synaptic vesicle protein 2A (SV2A) receptors on neuronal membranes. This binding reduces excessive neuronal firing in the brain, thereby inhibiting the propagation of seizure-inducing electrical impulses.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Epitra 500 Tablet is inadvisable.
PregnancySAFE IF PRESCRIBED
Use of Epitra 500 Tablet during pregnancy is considered safe. Research largely indicates minimal to no harm to the fetus.
Breast feedingSAFE IF PRESCRIBED
Using Epitra 500 Tablet while breastfeeding is likely safe. Available human data indicates minimal risk to the infant. Observe the infant for drowsiness and satisfactory weight increase.
DrivingUNSAFE
Taking Epitra 500 Tablet might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use Epitra 500 Tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Epitra 500 Tablet appears safe for use in individuals with liver conditions. Current evidence indicates dose modification may be unnecessary for most; however, patients with severe liver impairment might benefit from a reduced dosage. Physician consultation is recommended.
What if you forget to take Epitra 500 Tablet :
Should you forget to take your Epitra 500 Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Epitra 500 Tablet
| Label | Value |
|---|---|
| Chemical Category | Pyrrolidinone-Acetamide Derivative |
| Developing Habits | No. |
| Treatment Category | Neuroscience and Central Nervous System |
| Actions | AED: A protein ligand within synaptic vesicle 2 |




